Zhou, Kunlin
Wang, Lei
Sun, Zhiyuan
Liu, Yuelin
Zhu, Yufu
Liu, Zhiyi
Zhang, Bin
Shi, Hengliang http://orcid.org/0000-0002-9649-1910
Funding for this research was provided by:
the national natural science foundation of china (81874081)
the young science and technology innovation team of xuzhou medical university (TD202006)
the foundation of xuzhou science and technology bureau (KC20139, KC20128, KC20091)
the jiangsu provincial qing lan project and jiangsu provincial medical youth talent (QNRC2016784)
the foundation of jiangsu provincial health department (M2020082)
the national innovation and entrepreneurship training program for college students (201910313026, 201910313019Z)
the natural science foundation of jiangsu province of china (BK20181149)
Article History
Received: 17 June 2021
Accepted: 2 November 2021
First Online: 27 January 2022
Change Date: 17 May 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s12035-022-02865-9
Declarations
:
: The experimental protocol for human glioma tissues were obtained from the Affiliated Hospital of Xuzhou Medical University. This study was approved by the Ethics Committee of the Affiliated Hospital of Xuzhou Medical University.
: Glioma patients signed an internal regulatory document, stating that residual samples used for diagnostic procedures can be used for retrospective academic studies, without any additional informed consent.
: Not applicable.
: The authors declare no competing interests.